Literature DB >> 6170084

Electroconvulsive therapy (ECT) increases plasma growth hormone, prolactin, luteinising hormone and follicle-stimulating hormone but not thyrotropin or substance P.

P Skrabanek, A Balfe, M Webb, J Maguire, D Powell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6170084     DOI： 10.1016/0306-4530(81)90036-6

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN： 0306-4530            Impact factor:   4.905


× No keyword cloud information.
  5 in total

1.  Sarcoidosis, anterior pituitary failure, and diabetes insipidus.

Authors:  P Garrett; C Langan; J Egan; E Mulloy; J O'Donnell
Journal:  Ir J Med Sci       Date:  1983-03       Impact factor: 1.568

2.  Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment.

Authors:  E Widerlöv; R Ekman; L Jensen; L Borglund; K Nyman
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  Plasma prolactin concentrations following epileptic and pseudoseizures.

Authors:  W C Collins; O Lanigan; N Callaghan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

4.  Changes in serum prolactin after electroconvulsive and epileptic seizures.

Authors:  F Johansson; L von Knorring
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

5.  The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.

Authors:  A Weizman; I Gil-Ad; D Grupper; S Tyano; Z Laron
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.